NATIONAL HOME INFUSION ASSOCIATION RELEASES FIRST-EVER STUDY OF ALTERNATE-SITE INFUSION INDUSTRY
Report Outlines Key Provider Demographics, Therapy Utilization and Implications for Future Data Collection Efforts
Washington, DC -- The National Home Infusion Association (NHIA) today released a comprehensive first-ever analysis of the alternate-site infusion field that provides demographic information about the industry’s size and scope, including: patients served, therapies provided, and revenue earned. The study represents the first phase of an extensive, multi-year data collection effort designed to establish financial, operational, human resource and clinical benchmarks that will be utilized to enhance standards of patient care and chart the long-term strategic growth of the industry.
The study, 2010 NHIA Provider Survey Comprehensive Analysis Report, gathers national statistics from across the full spectrum of alternate-site infusion organizations including single site, multi-site and national health care providers of infusion therapy. The compendium provides an in-depth analysis of multiple data points such as the number of patients by age and therapy categories; revenue by therapy and payer type and full-time equivalent staffing for key positions; and providers’ pump utilization.
The report enables alternate-site health care providers to benchmark themselves against a “typical home infusion provider location,” and to further refine their comparisons based on provider type: single-site, multi-site or national. Among the key findings:
- In 2008, 730 NHIA member provider locations administered approximately 1.24 million therapies to an estimated 829,000 unique patients, with an average of 1.5 therapies per patient.
- NHIA member provider locations earned a combined total revenue of between $4.5 and $6.5 billion and employed between 15,000 and 20,000 full time equivalent staffing positions in 2008.
“Industry-wide benchmarking is vital in establishing best practices to strengthen organizational performance and improve quality of care to patients,” said NHIA President and CEO Russell Bodoff. "This is particularly important as our entire health care system undergoes dramatic transformation and the need to provide cost-efficient quality care to patients becomes increasingly vital. This groundbreaking baseline study is the first to bring together reliable, nationally representative data that in the long-term will allow the industry to enhance patient care, innovate and strengthen operational effectiveness."
“Over the past 25 years, home infusion therapy has proven to be a safe and economical option in lieu of institutionalized care for many patients receiving intravenous medications,” said Mary Ann Cope, President and CEO, HomeChoice Partners, Inc, and NHIA Board Chair. “This survey provides an extensive collection of foundational data that will support industry-wide benchmarking activities as home infusion providers continuously seek to improve health outcomes and an enhanced quality of life for patients. This report is a valuable tool for providers and other health care professionals, as well as suppliers to the industry.”
Future iterations of the NHIA data initiative study will include tracking trends in growth and defining measures for clinical outcomes.
The report is available from the NHIA website at www.nhia.org/data/purchase
The National Home Infusion Association, based in Alexandria, Virginia, is a trade association that represents and advances the interests of organizations that provide infusion and specialized pharmacy products and services to the entire spectrum of home-based patients. Infusion therapy involves the administration of medication through a needle or catheter, and is prescribed for infections unresponsive to oral antibiotics, cancer-related pain, dehydration, gastrointestinal disorders, congestive heart failure, Crohn's Disease, hemophilia, immune deficiencies, multiple sclerosis, and rheumatoid arthritis, among many other conditions. For more information, visit the association at www.nhia.org